The effect of prostaglandin E2 on transcriptional responses of Candida albicans
Lilly's massive R&D budget has also allowed it to focus on retatrutide, a so-called "triple-agonist" combining GLP-1 properties with other medications, that is currently in trial.
However, if you are experiencing significant caloric restriction, you may need to temporarily reduce exercise intensity whilst your body adapts
Like any treatment, it may have side effects and is not suitable for everyone
Small-scale clinical trials and cohort studies have also reported decreased substance cravings and relapse rates among individuals treated with GLP-1 RAs (2024)
Future research on GLP-1-based medicines for weight reduction must prioritize the precise evaluation of muscle mass, composition, and functionality to clarify their impact on muscular health